Unilateral Deep Brain Stimulation (DBS) of the Nucleus (Nucl.) Accumbens (Acc.) in Patients With Treatment Resistant Obsessive Compulsive Disorder (OCD)
1 other identifier
interventional
16
1 country
1
Brief Summary
The purpose of the study was to evaluate whether a unilateral Deep Brain Stimulation of the right Nucleus Accumbens could lead to a more than 35% reduction of symptoms in patients with a treatment resistant Obsessive Compulsive Disorder within two years.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Feb 2004
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2004
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2007
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2008
CompletedFirst Submitted
Initial submission to the registry
July 25, 2008
CompletedFirst Posted
Study publicly available on registry
July 29, 2008
CompletedJuly 29, 2008
July 1, 2008
3.6 years
July 25, 2008
July 28, 2008
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Yale-Brown Obsessive Compulsive Scale
Baseline (preoperative), 1week, 3 months, 6 months, 9 months, 12 months, 18 months, 24 months
Secondary Outcomes (1)
Beck Depression Inventory
Baseline (preoperative), 1 week, 3 months, 6 months, 9 months, 12 months, 18 months, 24 months
Interventions
Unilateral Deep Brain Stimulation in the right Nucleus Accumbens
Eligibility Criteria
You may qualify if:
- Obsessive compulsive disorder (according to DSM IV-criteria) as the primary psychiatric diagnosis
- severity level of OCD more than 25 on the Yale-Brown Obsessive Compulsive Scale
- course of illness had to have been present for at least five years in a chronic or progressive form despite any treatment trials (treatment resistance)
- treatment resistance: at least two serotonin reuptake inhibitors (SSRI´s), or one SSRI and clomipramine in sufficient dosages for at least 10 weeks, an augmentation trial with lithium, buspirone or a neuroleptic lasting at least 10 weeks, and complete cognitive-behavioral psychotherapy, including "exposure and response prevention" of a minimum of 20 sessions with a documented lack of efficiency
- the ability to give written and informed consent
You may not qualify if:
- co-morbid psychotic disorder according to DSM-IV criteria
- suicidal tendencies in the last 6 months
- history of cerebral trauma
- clinically relevant internal or neurological disorder
- substance misuse or dependence in the last six months
- ineligibility to fulfill the neurosurgical and anesthesiological preconditions for the implantation of a DBS
- pregnancy
- lactation period
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Psychiatry, University of Cologne
Cologne, North Rhine-Westphalia, 50924, Germany
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Joachim Klosterkötter, MD
Department of Psychiatry, Head of Department, University of Cologne
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
July 25, 2008
First Posted
July 29, 2008
Study Start
February 1, 2004
Primary Completion
September 1, 2007
Study Completion
February 1, 2008
Last Updated
July 29, 2008
Record last verified: 2008-07